Cerity Partners’s Faeth Therapeutics FTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$279K Buy
+9,378
New +$292K ﹤0.01% 2867

Other funds holding FTH

Cerity Partners's FTH Position: Q3 2026 in Review

Cerity Partners opened a new position in Faeth Therapeutics (FTH) in Q3 2026: 9,378 shares worth $279K. The stake represents ﹤0.01% of the portfolio and ranks #2867 among its holdings.

79 funds tracked by Wall St. Rank hold FTH as of Q3 2026.

  • Cerity Partners held 9,378 shares of Faeth Therapeutics worth $279K as of Q3 2026.
  • Faeth Therapeutics was a new Cerity Partners position in Q3 2026.
  • Faeth Therapeutics made up ﹤0.01% of Cerity Partners's portfolio in Q3 2026, its #2867 holding.
  • 79 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q3 2026.

Based on Cerity Partners's 13F filing for Q3 2026, filed 13 Nov 2026.